Data Animal Data In pregnant rats given twice weekly subcutaneous doses of 0.02, 0.1, and 0.5 mg/kg tirzepatide (0.03-, 0.07-, and 0.5-fold the MRHD of 15 mg once weekly based on AUC) during organogenesis, increased incidences of external, visceral, and skeletal malformations, increased incidences of visceral and skeletal developmental variations, and decreased fetal weights coincided with pharmacologically-mediated reductions in maternal body weights and food consumption at 0.5 mg/kg
Self-medication without medical consultation is not advisable for those with diagnosed liver conditions
Neurological & Brain Health Recovery We specialize in the "metabolic repair" of the brain
Rodrigo, R., Prat, H., Passalacqua, W., Araya, J., Guichard, C., & Bchler, J
Managing stress is a beneficial part of an overall wellness plan but is not a primary treatment for low platelets
Recommended Use Take 1 sachet in the morning, 30 minutes before breakfast